Urinary 8-hydroxydeoxyguanosine and urothelial carcinoma risk in low arsenic exposure area.

[1]  P. Deininger,et al.  8‐Hydroxy‐2′‐deoxyguanosine (8‐OH‐dG) as a potential survival biomarker in patients with nonsmall‐cell lung cancer , 2007, Cancer.

[2]  Y. Hsueh,et al.  Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure. , 2007, Toxicology and applied pharmacology.

[3]  M. Dizdaroglu,et al.  Oxidative Changes in the DNA of Stroma and Epithelium from the Female Breast: Potential Implications for Breast Cancer , 2006, Cell cycle.

[4]  Soile Tapio,et al.  Arsenic in the aetiology of cancer. , 2006, Mutation research.

[5]  Yuri Hibino,et al.  Evaluation of urinary 8-hydroxydeoxyguanine in healthy Japanese people. , 2006, Basic & clinical pharmacology & toxicology.

[6]  Louis W. Chang,et al.  Effects of arsenic exposure among semiconductor workers: a cautionary note on urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine. , 2006, Free radical biology & medicine.

[7]  M. Valko,et al.  Free radicals, metals and antioxidants in oxidative stress-induced cancer. , 2006, Chemico-biological interactions.

[8]  T. Mizoue,et al.  Leanness, Smoking, and Enhanced Oxidative DNA Damage , 2006, Cancer Epidemiology Biomarkers & Prevention.

[9]  K. Tamae,et al.  Occupational and lifestyle factors and urinary 8‐hydroxydeoxyguanosine , 2005, Cancer science.

[10]  Te-Chang Lee,et al.  Distinct Gene Expression Profiles in Immortalized Human Urothelial Cells Exposed to Inorganic Arsenite and Its Methylated Trivalent Metabolites , 2005, Environmental health perspectives.

[11]  Y. Hsueh,et al.  Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. , 2005, Toxicology and applied pharmacology.

[12]  M. Ihnat,et al.  Role of HIF signaling on tumorigenesis in response to chronic low-dose arsenic administration. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[13]  Sanjay Jain,et al.  Garlic supplementation prevents oxidative DNA damage in essential hypertension , 2005, Molecular and Cellular Biochemistry.

[14]  D. Levy,et al.  Smoking behaviour in Taiwan, 2001 , 2005, Tobacco Control.

[15]  C. Steinmaus,et al.  Intraindividual Variability in Arsenic Methylation in a U.S. Population , 2005, Cancer Epidemiology Biomarkers & Prevention.

[16]  S. Manna,et al.  Low levels of arsenite activates nuclear factor‐κB and activator protein‐1 in immortalized mesencephalic cells , 2005, Journal of biochemical and molecular toxicology.

[17]  J. Pi,et al.  Evaluation of DNA damage in patients with arsenic poisoning: urinary 8-hydroxydeoxyguanine. , 2004, Toxicology and applied pharmacology.

[18]  Takahiko Yoshida,et al.  Chronic health effects in people exposed to arsenic via the drinking water: dose-response relationships in review. , 2004, Toxicology and applied pharmacology.

[19]  S. Okada,et al.  The role of active arsenic species produced by metabolic reduction of dimethylarsinic acid in genotoxicity and tumorigenesis. , 2004, Toxicology and applied pharmacology.

[20]  M. Bates,et al.  ARSENIC METHYLATION AND BLADDER CANCER RISK IN CASE-CONTROL STUDIES FROM ARGENTINA AND THE UNITED STATES , 2004, Journal of occupational and environmental medicine.

[21]  L. Hudson,et al.  Arsenite causes DNA damage in keratinocytes via generation of hydroxyl radicals. , 2004, Chemical research in toxicology.

[22]  Margaret R. Karagas,et al.  Incidence of Transitional Cell Carcinoma of the Bladder and Arsenic Exposure in New Hampshire , 2004, Cancer Causes & Control.

[23]  H. Miyake,et al.  Oxidative DNA damage in patients with prostate cancer and its response to treatment. , 2004, The Journal of urology.

[24]  M. Bates,et al.  Case-control study of bladder cancer and exposure to arsenic in Argentina. , 2004, American journal of epidemiology.

[25]  M. Dean,et al.  Effect of a 4-Month Tea Intervention on Oxidative DNA Damage among Heavy Smokers , 2004, Cancer Epidemiology Biomarkers & Prevention.

[26]  M. Schmitt,et al.  Effects of arsenic on telomerase and telomeres in relation to cell proliferation and apoptosis in human keratinocytes and leukemia cells in vitro. , 2003, Carcinogenesis.

[27]  A. Kurimasa,et al.  Expression of 8‐hydroxy‐2′‐deoxyguanosine in chronic liver disease and hepatocellular carcinoma , 2003, Liver international : official journal of the International Association for the Study of the Liver.

[28]  S. Wiseman,et al.  Effect of increased tea consumption on oxidative DNA damage among smokers: a randomized controlled study. , 2003, The Journal of nutrition.

[29]  T. Akçay,et al.  Increased Formation of 8-Hydroxy-2’-Deoxyguanosine in Peripheral Blood Leukocytes in Bladder Cancer , 2003, Urologia Internationalis.

[30]  M. Blasco,et al.  Oxidative Stress Contributes to Arsenic-induced Telomere Attrition, Chromosome Instability, and Apoptosis* , 2003, Journal of Biological Chemistry.

[31]  K. Tsao,et al.  Urinary 8-hydroxydeoxyguanosine and its analogs as DNA marker of oxidative stress: development of an ELISA and measurement in both bladder and prostate cancers. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[32]  H. Makino,et al.  Significance of 8‐hydroxy‐2′‐deoxyguanosine levels in patients with chronic renal failure , 2003, Nephrology.

[33]  Thomas J. Smith,et al.  Arsenic methylation and bladder cancer risk in Taiwan , 2003, Cancer Causes & Control.

[34]  Y. Hsueh,et al.  Stability of arsenic species and insoluble arsenic in human urine. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[35]  K. G. Brown,et al.  Arsenic, drinking water, and health: a position paper of the American Council on Science and Health. , 2002, Regulatory toxicology and pharmacology : RTP.

[36]  K. Roszkowski,et al.  The level of 8-hydroxyguanine, a possible repair product of oxidative DNA damage, is higher in urine of cancer patients than in control subjects. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[37]  C. Tseng.  An Overview on Peripheral Vascular Disease in Blackfoot Disease-Hyperendemic Villages in Taiwan , 2002, Angiology.

[38]  S. Fukushima,et al.  Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors. , 2002, Carcinogenesis.

[39]  S. Fukushima,et al.  Promoting effects of monomethylarsonic acid, dimethylarsinic acid and trimethylarsine oxide on induction of rat liver preneoplastic glutathione S‐transferase placental form positive foci: A possible reactive oxygen species mechanism , 2002, International journal of cancer.

[40]  C. Hopenhayn-Rich,et al.  Evidence for induction of oxidative stress caused by chronic exposure of Chinese residents to arsenic contained in drinking water. , 2002, Environmental health perspectives.

[41]  C. Rice-Evans,et al.  Gender Differences in Steady-state Levels of Oxidative Damage to DNA in Healthy Individuals , 2002, Free radical research.

[42]  Y. Hsueh,et al.  Association of blood arsenic levels with increased reactive oxidants and decreased antioxidant capacity in a human population of northeastern Taiwan. , 2001, Environmental health perspectives.

[43]  C. Chen,et al.  Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. , 2001, American journal of epidemiology.

[44]  H. Iso,et al.  Decreased serum concentrations of nitric oxide metabolites among Chinese in an endemic area of chronic arsenic poisoning in inner Mongolia. , 2000, Free radical biology & medicine.

[45]  K. Jan,et al.  NADH oxidase activation is involved in arsenite-induced oxidative DNA damage in human vascular smooth muscle cells. , 2000, Circulation research.

[46]  Y. Hsueh,et al.  Urinary levels of inorganic and organic arsenic metabolites among residents in an arseniasis-hyperendemic area in Taiwan. , 1998, Journal of toxicology and environmental health. Part A.

[47]  C. Pritsos,et al.  Environmental tobacco smoke in the workplace induces oxidative stress in employees, including increased production of 8-hydroxy-2'-deoxyguanosine. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[48]  Xianglin Shi,et al.  Molecular mechanisms of arsenic carcinogenesis , 2004, Molecular and Cellular Biochemistry.

[49]  J. A. Roberson,et al.  Some drinking-water disinfectants and contaminants, including arsenic. , 2004, IARC monographs on the evaluation of carcinogenic risks to humans.

[50]  Craig Steinmaus,et al.  Case-control study of bladder cancer and drinking water arsenic in the western United States. , 2003, American journal of epidemiology.

[51]  Y. Hasui,et al.  Quantitative determination of urinary 8-hydroxydeoxyguanosine (8-OH-dg) by using ELISA. , 2000, Research communications in molecular pathology and pharmacology.

[52]  S. Loft,et al.  Cancer risk and oxidative DNA damage in man , 1997, Journal of Molecular Medicine.